Dorsey & Whitney Trust’s Pfizer PFE Stock Holding History

Dorsey & Whitney Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.72M	Buy	61,150 +1,089	+2%	+$29K	0.09%	192
2025 Q4	$1.5M	Sell	60,061 -8,187	-12%	-$206K	0.08%	208
2025 Q3	$1.74M	Sell	68,248 -13,845	-17%	-$342K	0.09%	180
2025 Q2	$1.99M	Buy	82,093 +1,120	+1%	+$26.1K	0.11%	169
2025 Q1	$2.05M	Buy	80,973 +7,814	+11%	+$204K	0.12%	158
2024 Q4	$1.94M	Sell	73,159 -31,059	-30%	-$842K	0.11%	168
2024 Q3	$3.02M	Buy	104,218 +26,812	+35%	+$782K	0.16%	121
2024 Q2	$2.17M	Buy	77,406 +4,939	+7%	+$136K	0.15%	126
2024 Q1	$2.01M	Buy	72,467 +9,989	+16%	+$277K	0.14%	133
2023 Q4	$1.8M	Sell	62,478 -7,495	-11%	-$227K	0.14%	145
2023 Q3	$2.32M	Sell	69,973 -11,389	-14%	-$403K	0.2%	118
2023 Q2	$2.98M	Sell	81,362 -468	-0.6%	-$18.2K	0.25%	101
2023 Q1	$3.34M	Sell	81,830 -7,150	-8%	-$309K	0.3%	86
2022 Q4	$4.56M	Sell	88,980 -5,106	-5%	-$245K	0.44%	58
2022 Q3	$4.12M	Sell	94,086 -2,685	-3%	-$130K	0.43%	58
2022 Q2	$5.07M	Sell	96,771 -12,951	-12%	-$660K	0.52%	50
2022 Q1	$5.68M	Sell	109,722 -14,241	-11%	-$739K	0.5%	50
2021 Q4	$7.32M	Sell	123,963 -1,966	-2%	-$97.4K	0.61%	48
2021 Q3	$5.42M	Sell	125,929 -3,991	-3%	-$177K	0.5%	52
2021 Q2	$5.09M	Sell	129,920 -14,173	-10%	-$551K	0.48%	55
2021 Q1	$5.22M	Buy	144,093 +23,363	+19%	+$830K	0.52%	51
2020 Q4	$4.44M	Sell	120,730 -10,051	-8%	-$369K	0.52%	47
2020 Q3	$4.55M	Sell	130,781 -11,703	-8%	-$410K	0.61%	41
2020 Q2	$4.42M	Sell	142,484 -7,093	-5%	-$241K	0.62%	40
2020 Q1	$4.63M	Sell	149,577 -9,455	-6%	-$322K	0.78%	35
2019 Q4	$5.91M	Buy	159,032 +1,823	+1%	+$64.9K	0.79%	36
2019 Q3	$5.36M	Buy	157,209 +2,822	+2%	+$103K	0.79%	34
2019 Q2	$6.34M	Buy	154,387 +1,503	+1%	+$59.7K	0.98%	23
2019 Q1	$6.16M	Sell	152,884 -11,405	-7%	-$457K	0.96%	26
2018 Q4	$6.8M	Sell	164,289 -4,689	-3%	-$195K	1.2%	18
2018 Q3	$7.07M	Sell	168,978 -2,925	-2%	-$113K	1.1%	22
2018 Q2	$5.92M	Sell	171,903 -3,212	-2%	-$110K	1.03%	27
2018 Q1	$5.9M	Sell	175,115 -8,128	-4%	-$279K	1.08%	32
2017 Q4	$6.29M	Sell	183,243 -3,638	-2%	-$124K	1.16%	26
2017 Q3	$6.33M	Buy	186,881 +5,903	+3%	+$190K	1.26%	23
2017 Q2	$5.77M	Buy	180,978 +4,227	+2%	+$133K	1.15%	25
2017 Q1	$5.74M	Buy	176,751 +22,207	+14%	+$700K	1.17%	27
2016 Q4	$4.76M	Buy	154,544 +466	+0.3%	+$14.2K	1.08%	32
2016 Q3	$4.95M	Sell	154,078 -3,978	-3%	-$133K	1.13%	32
2016 Q2	$5.28M	Buy	158,056 +10,672	+7%	+$341K	1.21%	28
2016 Q1	$4.12M	Buy	147,384 +18,257	+14%	+$521K	1.03%	32
2015 Q4	$3.95M	Buy	129,127 +8,263	+7%	+$260K	1.04%	30
2015 Q3	$3.6M	Buy	120,864 +8,741	+8%	+$280K	1.01%	29
2015 Q2	$3.57M	Buy	112,123 +2,210	+2%	+$72K	0.91%	33
2015 Q1	$3.63M	Sell	109,913 -2,931	-3%	-$93.2K	0.92%	32
2014 Q4	$3.33M	Sell	112,844 -3,564	-3%	-$102K	0.86%	37
2014 Q3	$3.27M	Sell	116,408 -2,292	-2%	-$64.3K	0.88%	36
2014 Q2	$3.36M	Buy	118,700 +1,119	+1%	+$31.9K	0.73%	36
2014 Q1	$3.58M	Sell	117,581 -11,042	-9%	-$329K	0.82%	33
2013 Q4	$3.74M	Sell	128,623 -2,875	-2%	-$83.7K	1.02%	31
2013 Q3	$3.58M	Buy	131,498 +5,382	+4%	+$146K	1.07%	29
2013 Q2	$3.35M	Buy	+126,116	New	+$3.48M	1.11%	29

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Dorsey & Whitney Trust's PFE Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Pfizer (PFE) stake by 1.8% in Q1 2026, buying an estimated $29K and bringing the position to 61,150 shares worth $1.72M. The position accounts for 0.09% of the portfolio, ranked #192.

Dorsey & Whitney Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.32M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Dorsey & Whitney Trust held 61,150 shares of Pfizer worth $1.72M as of Q1 2026.
Dorsey & Whitney Trust bought 1,089 Pfizer shares in Q1 2026, an estimated $29K.
Pfizer made up 0.09% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #192 holding.
Dorsey & Whitney Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Dorsey & Whitney Trust's Pfizer position peaked at $7.32M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.